Application forms for NSW authorisation to prescribe or supply Schedule 8 (S8) drugs are listed below. Note that forms may be updated from time to time.

Please note that a number of authority application forms have recently been updated. Old application forms are no longer be accepted.

If you have any questions or would like to provide feedback on the new application forms, please email: MOH-S8Auth@health.nsw.gov.au

Information on legal requirements for an authority to prescribe drugs of addiction in NSW are also available.

On this page

1. Pain management
2. Attention Deficit Hyperactivity Disorder (ADHD) in a child, adolescent, or adult
3. Psychostimulant for treatment of a diagnosis other than ADHD
4. Alprazolam and flunitrazepam
5. NSW Opioid Treatment Program (OTP)
6. Certain restricted substances
7. Unregistered or (pharmacy) extemporaneously-compounded S8 product
8. Cannabis medicines
9. Esketamine or ketamine for treatment resistant depression
10. Human research (Clinical trial)
11. Psilocybine or MDMA

Pain management

To apply for authorisation to prescribe or supply a Schedule 8 opioid (e.g. oxycodone, morphine or fentanyl) or another S8 drug for the management of pain in a patient, complete an Application for authority to prescribe or supply a Schedule 8 drug - pain management.

Attention Deficit Hyperactivity Disorder (ADHD) in a child, adolescent, or adult

The application for the treatment of ADHD in an adult has now merged into one form – a combined application form for ADHD for children, adolescents, adults, and high dose.

To apply for authorisation to prescribe or supply a psychostimulant (dexamfetamine, lisdexafetamine or methlyphenidate) for the management of ADHD in a child, adolescent, or adult patient, complete an Application for authority to prescribe or supply a Schedule 8 drug - Psychostimulant for Attention Deficit Hyperactivity Disorder (ADHD).

The same application form may be used to prescribe a high dose of psychostimulant for the management of ADHD in a child, adolescent, or adult.

Psychostimulant for treatment of an indication other than ADHD

To apply for authorisation to prescribe a psychostimulant for the management of a diagnosis other than ADHD in a child, adolescent, or adult patient, complete an Application for authority to prescribe or supply a Schedule 8 psychostimulant, other than for ADHD, for children and adults.

Alprazolam and flunitrazepam

To apply for authorisation to prescribe or supply alprazolam or flunitrazepam, complete an Application for authority to prescribe a Schedule 8 drug - alprazolam or flunitrazepam.

NSW Opioid Treatment Program (OTP)

Applications for authority to prescribe or supply methadone, buprenorphine or other opioid agonist therapy (OAT) treatment under the NSW OTP are to be made using one form (rather than a separate form for each drug). To apply for authorisation complete an Application for authority to prescribe methadone, buprenorphine or other opioid agonist therapy (OAT) treatment under the NSW Opioid Treatment Program (updated form).

Please note that from 22 May 2023 the old OTP forms will no longer be accepted.

Prescribers wishing to apply for authority to prescribe or supply high dose methadone or buprenorphine please use Application for authority to prescribe or supply methadone (>200mg/day) or buprenorphine (>32mg/day) under the NSW Opioid Treatment Program (updated form).

Interstate prescribers who wish to temporarily transfer a patient to the NSW OTP are required to complete an Application for temporary interstate transfer to NSW Opioid Treatment Program (updated form).

To exit a person from the NSW OTP complete an Exit from methadone, buprenorphine or other opioid agonist therapy (OAT) treatment under the NSW Opioid Treatment Program.

Certain restricted substances

To apply for authorisation to prescribe the certain restricted substances (acitretin, clomifene, cyclofenil, dinoprost, dinoprostone, etretinate, follitropin beta, hydroxychloroquine, isotretinoin for oral use, luteinising hormone, tretinoin for oral use, urofollitrophin (human follicle stimulating hormone)) complete an Application for authority to prescribe certain restricted substances.

The Authority under the Poisons and Therapeutic Goods Regulation 2008 enables prescribers at a public or private hospital to direct the administration of certain restricted substances to an inpatient commenced on the medication in the community.

Unregistered or (pharmacy) extemporaneously-compounded S8 product

To apply for authorisation to prescribe or supply an extemporaneously-compounded Schedule 8 product or an unregistered S8 medicine (other than a cannabis medicine) complete an Application for authority to prescribe an unregistered or (pharmacy) extemporaneously - compounded Schedule 8 product for human therapeutic use.

Cannabis medicines

To apply for authorisation to prescribe or supply a cannabis-based product for therapeutic use complete an Application for authority to prescribe or supply a Schedule 8 cannabis medicine for human therapeutic use.

Esketamine or ketamine for treatment resistant depression

To apply for authorisation to prescribe esketamine, complete an Application for authority to prescribe or supply esketamine or ketamine for treatment resistant depression.

Human research (Clinical trial)

To apply for authorisation to prescribe and supply a substance for the purpose of human research complete an Application for authority to prescribe and supply a substance for the purpose of human research.

Psilocybine or MDMA

To prescribe psilocybine for the treatment of depression resistant to other treatments, or MDMA for the treatment of post-traumatic stress disorder (PTSD), a prescriber with approval under the TGA Authorised Prescriber scheme will require an authority from NSW Ministry of Health. To apply complete an Application for Authority to Prescribe or Supply Unregistered Psychedelics-Psilocybine or MDMA.